Wednesday, 20 Nov 2019

You are here

Steroids in GCA and PMR Increase Infectious Risk

A large study of UK family practice patients shows that polymyalgia rheumatica (PMR) or giant cell arteritis (GCA) patients treated with glucocorticoids are at an increased risk of bacterial, viral, parasitic and fungal infection, even at daily doses of less than 5 mg prednisolone.

A retrospective, medical record review of 389 UK family practices identified 39,938 patients between 1998–2017, estimated the first occurring infection and related that to their dose of glucocorticoids.

Overall, over half (2234 or 55.7%) of PMR and GCA had at least 1 infection over a 4.8 year follow-up period.  Hospitalization was required in half of these (5937 or 26.7%) and 7.3% died within 7 days of diagnosis.

Time related, all cause risks for infection were:

  • at 1 year - 18.3% (17.9%–18.7%)
  • at 5 years - 54.7% (54.1%–55.2%)
  • at 10 years 76.9% (76.2%–77.5%)

The most common were lower respiratory tract infections, conjunctivitis and herpes zoster.

For each 5 mg prednisolone-equivalent daily dose increase there was a corresponding increase in infection risk.

Glucocorticoid exposure increased the risk of fungal inection (HR 1.48;1.39–1.57) and bacterial infections (HR 1.70;1.60–1.80). Similar increases were seen for viral and parasitic infections, irrespective of patient age, duration of underlying chronic disease and baseline vaccination status.


The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Part 1:  The “P” in Prednisone stands for Poison...and Other Pearls

Everyone has life hacks.  Years of experience and doing the same things repetitively allow us to figure out little tricks to make life easier. A rat in a maze, finding itself at a dead end, will back up and search for a clearing. If this rat encounters its neighbor, it will transmit that information so the second rat won’t make the same mistake.

Protective Effects of ASA and Vasodilators in Systemic Sclerosis

A large cohort study suggests that the use of vasodilators and aspirin (ASA) in systemic sclerosis (SSc) may yield favorable  cardiovascular outcomes.

Myositis Patients at High Risk of Opportunistic Infections

Among patients with systemic rheumatic diseases, the highest incidence of opportunistic infections was seen in those with polymyositis/dermatomyositis (PM/DM), Taiwanese researchers found.

Warfarin Superior to Xarelto in Antiphospholipid Syndrome

A 3 year, multicenter, European, study shows that rivaroxaban was inferior to warfarin in preventing thrombosis in patients with antiphospholipid syndrome (APS) according to the Annals of Internal Medicine. Thus despite the inconvenience of warfarin, it remains the best option for patients with APS.

Declining Trends in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis Mortality in the USA

Annals of Internal Medicine reports that age-adjusted mortality rates for antineutrophil cytoplasmic autoantibody–associated vasculitides (AAV) have improved over time - with a decline of nearly 2 percent per year in the United States from 1999 to 2017. Nevertheless, long-term outcomes continue to lag behind mortality rates of the general population.